Richard Wiegand

Phase I Clinical Trial of BMS-247550, A Derivative of Epothilone B, Using Accelerated Titration 2B Design

Shirish M. Gadgeel, Antoinette J. Wozniak, Ramesh Boinpally et al. · Clinical Cancer Research · 2005 · 75 citations

Medicine, Oncology, Pharmacology +8

Methylation suppresses the proteasome‐inhibitory function of green tea polyphenols

Kristin R. Landis‐Piwowar, Sheng Wan, Richard Wiegand et al. · Journal of Cellular Physiology · 2007 · 65 citations

Life Sciences, Biochemistry, Pharmacology +14

Quantitative analysis of intracellular nucleoside triphosphates and other polar metabolites using ion pair reversed-phase liquid chromatography coupled with tandem mass spectrometry

Jianmei Wu, Yingtao Zhang, Richard Wiegand et al. · Journal of Chromatography B · 2015 · 42 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +17

A stable isotope-labeled internal standard is essential for correcting for the interindividual variability in the recovery of lapatinib from cancer patient plasma in quantitative LC–MS/MS analysis

Jianmei Wu, Richard Wiegand, Patricia LoRusso et al. · Journal of Chromatography B · 2013 · 42 citations

Pharmacy, Oncology, Pharmaceutical Analysis +12

Preclinical anticancer activity of cryptophycin-8.

T. H. CORBETT, Fred Valeriote, Lisa Demchik et al. · PubMed · 1996 · 39 citations

Medicine, Oncology, Pharmacology +10